202 related articles for article (PubMed ID: 30036258)
41. Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT.
Klein Nulent TJW; Valstar MH; de Keizer B; Willems SM; Smit LA; Al-Mamgani A; Smeele LE; van Es RJJ; de Bree R; Vogel WV
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):478-486. PubMed ID: 29523427
[TBL] [Abstract][Full Text] [Related]
42. 68Ga-Prostate-Specific Membrane Antigen PET/CT: Incidental Finding of a Liposarcoma.
Militano V; Afaq A; Bomanji J
Clin Nucl Med; 2019 Feb; 44(2):e90-e92. PubMed ID: 30608915
[TBL] [Abstract][Full Text] [Related]
43. Thrombosis of the Iliac Vein Detected by 64Cu-Prostate-Specific Membrane Antigen (PSMA) PET/CT.
Annunziata S; Rea S; Romano L; Mazzone C; Di Traglia S; Sciuto R
Clin Nucl Med; 2021 Jan; 46(1):e29-e30. PubMed ID: 33031241
[TBL] [Abstract][Full Text] [Related]
44. Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on
Werner RA; Bundschuh RA; Bundschuh L; Javadi MS; Leal JP; Higuchi T; Pienta KJ; Buck AK; Pomper MG; Gorin MA; Lapa C; Rowe SP
J Nucl Med; 2018 Dec; 59(12):1857-1864. PubMed ID: 30190304
[TBL] [Abstract][Full Text] [Related]
45. Large Paraesophageal Schwannoma With Intense Prostate-Specific Membrane Antigen Expression on 68Ga-PSMA-PET/CT Mimicking Lymph Node Metastasis in a Patient With Prostate Cancer.
Ries M; Khreish F; Veith C; von den Hoff J; Ezziddin S
Clin Nucl Med; 2019 Feb; 44(2):153-154. PubMed ID: 30371596
[TBL] [Abstract][Full Text] [Related]
46. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
47. Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging: The PSMA PET Progression Criteria.
Fanti S; Hadaschik B; Herrmann K
J Nucl Med; 2020 May; 61(5):678-682. PubMed ID: 31806774
[TBL] [Abstract][Full Text] [Related]
48. The Role of Positron Emission Tomography With (68)Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy.
Rai BP; Baum RP; Patel A; Hughes R; Alonzi R; Lane T; Adshead J; Vasdev N
Urology; 2016 Sep; 95():11-5. PubMed ID: 26790588
[TBL] [Abstract][Full Text] [Related]
49. 68Ga-PSMA PET/MR Showing Intense PSMA Uptake in Nodular Fasciitis Mimicking Prostate Cancer Metastasis.
Henninger M; Maurer T; Hacker C; Eiber M
Clin Nucl Med; 2016 Oct; 41(10):e443-4. PubMed ID: 27488427
[TBL] [Abstract][Full Text] [Related]
50. Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls.
Sheikhbahaei S; Werner RA; Solnes LB; Pienta KJ; Pomper MG; Gorin MA; Rowe SP
Semin Nucl Med; 2019 Jul; 49(4):255-270. PubMed ID: 31227049
[TBL] [Abstract][Full Text] [Related]
51. Intrapatient Comparison of 111In-PSMA I&T SPECT/CT and Hybrid 68Ga-HBED-CC PSMA PET in Patients With Early Recurrent Prostate Cancer.
Rauscher I; Maurer T; Souvatzoglou M; Beer AJ; Vag T; Wirtz M; Weirich G; Wester HJ; Gschwend JE; Schwaiger M; Schottelius M; Eiber M
Clin Nucl Med; 2016 Sep; 41(9):e397-402. PubMed ID: 27276206
[TBL] [Abstract][Full Text] [Related]
52. Therapy assessment in prostate cancer using choline and PSMA PET/CT.
Ceci F; Herrmann K; Hadaschik B; Castellucci P; Fanti S
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(Suppl 1):78-83. PubMed ID: 28540419
[TBL] [Abstract][Full Text] [Related]
53. Clinical impact of
Albisinni S; Artigas C; Aoun F; Biaou I; Grosman J; Gil T; Hawaux E; Limani K; Otte FX; Peltier A; Sideris S; Sirtaine N; Flamen P; van Velthoven R
BJU Int; 2017 Aug; 120(2):197-203. PubMed ID: 27981732
[TBL] [Abstract][Full Text] [Related]
54. Healing Sacral Fracture Masquerading as Metastatic Bone Disease on a 68Ga-PSMA PET/CT.
Gykiere P; Goethals L; Everaert H
Clin Nucl Med; 2016 Jul; 41(7):e346-7. PubMed ID: 27055135
[TBL] [Abstract][Full Text] [Related]
55. Hemangioblastoma: An Unsuspected Pitfall in PSMA PET/CT.
Gohimont N; Jissendi Tchofo P; Racu ML; Entezari K; Salmon I; Tondeur M; Ene D
Clin Nucl Med; 2021 Jun; 46(6):485-487. PubMed ID: 33492863
[TBL] [Abstract][Full Text] [Related]
56. Correlation of PSMA-Targeted
Tosoian JJ; Gorin MA; Rowe SP; Andreas D; Szabo Z; Pienta KJ; Pomper MG; Lotan TL; Ross AE
Clin Genitourin Cancer; 2017 Feb; 15(1):e65-e68. PubMed ID: 27751686
[No Abstract] [Full Text] [Related]
57. 68Ga-PSMA PET/CT False-Positive Tracer Uptake in Paget Disease.
Sasikumar A; Joy A; Nanabala R; Pillai MR; T A H
Clin Nucl Med; 2016 Oct; 41(10):e454-5. PubMed ID: 27556797
[TBL] [Abstract][Full Text] [Related]
58. PSMA-negative prostate cancer and the continued value of choline-PET/CT.
Alberts I; Sachpekidis C; Fech V; Rominger A; Afshar-Oromieh A
Nuklearmedizin; 2020 Feb; 59(1):33-34. PubMed ID: 31766065
[No Abstract] [Full Text] [Related]
59. Incidental Detection of Radiotracer Uptake in Intracranial Dermoid Cyst on 18F-Prostate-Specific Membrane Antigen PET/CT During Staging for Prostate Carcinoma.
Hod N; Levin D; Novoa R; Lantsberg S
Clin Nucl Med; 2021 May; 46(5):e273-e275. PubMed ID: 33323739
[TBL] [Abstract][Full Text] [Related]
60. Molecular imaging using PSMA PET/CT versus multiparametric MRI for initial staging of prostate cancer: comparing apples with oranges?
Mottaghy FM; Heinzel A; Verburg FA
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1397-9. PubMed ID: 27118189
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
